Phase I trial of sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation (LT).
A. B. Siegel
Research Funding - Bayer; Onyx
R. Hidalgo
No relevant relationships to disclose
D. Tsushima
No relevant relationships to disclose
J. Zaretsky
No relevant relationships to disclose
J. Emond
No relevant relationships to disclose
T. Kato
No relevant relationships to disclose
R. S. Brown
Honoraria - Onyx